Accessible Search Form           Advanced Search

James P. Kiley, Ph.D.

To arrange an interview, please contact the NHLBI Communications Office at 301-496-4236 or nhlbi_news@nhlbi.nih.gov.

Portrait of James Kiley.
James P. Kiley, Ph.D.

High Res JPG file (558 KB)

Biography

James P. Kiley, Ph.D., joined the National Heart, Lung, and Blood Institute (NHLBI) in 1984 as Health Scientist Administrator in the Institute's Division of Lung Diseases. From 1989-1994, Dr. Kiley served as Chief of the Division's Airways Diseases Branch. From 1995-2000 he served as Director of the National Center on Sleep Disorders Research, which is part of NHLBI. He was named Director of the Division of Lung Diseases in 2000. Dr. Kiley's primary research interests include obstructive and interstitial lung diseases and sleep.

Dr. Kiley received his M.S. and Ph.D. degrees from Kansas State University, Manhattan, KS in 1978 and 1982, respectively. He received his B.A. in 1974 from St. Anselm's College, Manchester, NH.

Dr. Kiley is the author or coauthor of more than 85 scientific publications and abstracts. He has served as a reviewer for the Journal of Applied Physiology, Chest, Respiratory Physiology, the Journal of the U.S. Public Health Service, and the Journal of Clinical Investigations.

Areas of expertise: obstructive and interstitial lung diseases, sleep.


Dr. Kiley In the News

June 24, 2014 : PhysOrg
Fantastic voyage into the human lung
A team of investigators at The Saban Research Institute of Children's Hospital Los Angeles has been awarded $4 million over five years by the National Heart Lung and Blood Institute (NHLBI) for LungMAP, an atlas of the developing human lung. Borrowing from Hollywood blockbusters, the researchers are employing state-of-the-art animation technology in combination with advanced optical imaging and high-resolution x-ray imaging techniques. This novel technology will allow them to explore the composition and interaction of cells in the developing lung and to follow how the processes evolve over time.

May 20, 2014 : Forbes
Disappointing results for statins in two NIH trials
Larry Husten
Two NHLBI studies have failed to find any benefit for statin therapy in patients with chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS)

View all Dr. Kiley in the news articles


Last Updated: April 12, 2012